<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tsompanidis, A.</style></author><author><style face="normal" font="default" size="100%">Vafiadaki, E.</style></author><author><style face="normal" font="default" size="100%">Bluher, S.</style></author><author><style face="normal" font="default" size="100%">Kalozoumi, G.</style></author><author><style face="normal" font="default" size="100%">Sanoudou, D.</style></author><author><style face="normal" font="default" size="100%">Mantzoros, C.S.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Ciliary neurotrophic factor upregulates follistatin and Pak1, causes overexpression of muscle differentiation related genes and downregulation of established atrophy mediators in skeletal muscle</style></title><secondary-title><style face="normal" font="default" size="100%">MetabolismMetabolismMetabolism</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Metabolism: clinical and experimental</style></alt-title><short-title><style face="normal" font="default" size="100%">Metabolism: clinical and experimentalMetabolism: clinical and experimental</style></short-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Animals</style></keyword><keyword><style  face="normal" font="default" size="100%">Atrophy/metabolism</style></keyword><keyword><style  face="normal" font="default" size="100%">Ciliary Neurotrophic Factor/*pharmacology</style></keyword><keyword><style  face="normal" font="default" size="100%">Down-Regulation/*drug effects</style></keyword><keyword><style  face="normal" font="default" size="100%">Follistatin/genetics/*metabolism</style></keyword><keyword><style  face="normal" font="default" size="100%">Gene Expression Regulation/drug effects</style></keyword><keyword><style  face="normal" font="default" size="100%">Male</style></keyword><keyword><style  face="normal" font="default" size="100%">Mice</style></keyword><keyword><style  face="normal" font="default" size="100%">Muscle, Skeletal/drug effects/*metabolism</style></keyword><keyword><style  face="normal" font="default" size="100%">Obesity/*metabolism</style></keyword><keyword><style  face="normal" font="default" size="100%">p21-Activated Kinases/genetics/*metabolism</style></keyword><keyword><style  face="normal" font="default" size="100%">Up-Regulation/*drug effects</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">Jun</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">6</style></number><volume><style face="normal" font="default" size="100%">65</style></volume><pages><style face="normal" font="default" size="100%">915-25</style></pages><isbn><style face="normal" font="default" size="100%">1532-8600 (Electronic)0026-0495 (Linking)</style></isbn><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">INTRODUCTION: The Ciliary Neurotrophic Factor (CNTF) is a pluripotent cytokine with anorexigenic actions in the hypothalamus that improves insulin sensitivity, increases energy expenditure and induces weight loss. Since CNTF also has an established myotrophic role, we sought to examine whether skeletal muscle contributes to the CNTF-induced metabolic improvement and identify the molecular mechanisms mediating these effects. METHODS: We used a mouse model of diet-induced obesity, to which high or low CNTF doses were administered for 7days. Whole transcriptome expression levels were analyzed in dissected soleus muscles using microarrays and data were then confirmed using qRT-PCR. RESULTS: We demonstrate that CNTF administration significantly downregulates leptin, while it upregulates follistatin and Pak1; a molecule associated with insulin sensitization in skeletal muscle. A significant overexpression of muscle differentiation related genes and downregulation of established atrophy mediators was observed. CONCLUSIONS: The overall gene expression changes suggest an indirect, beneficial effect of CNTF on metabolism, energy expenditure and insulin sensitivity, exerted by the pronounced stimulation of muscle growth, with similarities to the described effect of follistatin and the activation of the Akt pathway in skeletal muscle.</style></abstract><accession-num><style face="normal" font="default" size="100%">27173470</style></accession-num><notes><style face="normal" font="default" size="100%">Tsompanidis, AlexandrosVafiadaki, ElizabethBluher, SusannKalozoumi, GeorgiaSanoudou, DespinaMantzoros, Christos SengResearch Support, Non-U.S. Gov't2016/05/14 06:00Metabolism. 2016 Jun;65(6):915-25. doi: 10.1016/j.metabol.2016.03.005. Epub 2016 Mar 15.</style></notes><auth-address><style face="normal" font="default" size="100%">Clinical Genomics and Pharmacogenomics Unit, 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.Molecular Biology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.Clinical Genomics and Pharmacogenomics Unit, 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Molecular Biology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece. Electronic address: dsanoudou@med.uoa.gr.</style></auth-address></record></records></xml>